How a person's immune system responds to a protein called LL-37 may increase the risk of developing acute coronary syndrome, but the response may also serve as a potential target for future ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

In this Clinical Outlook, we describe available multiomic studies in cardiovascular medicine, discuss the advantages and potential of multiomic techniques for clinical translation in cardiology ...

Study Objectives: The clinical manifestations of acute coronary syndromes (ACSs) vary, and patients present frequently with symptoms other than chest pain. In this analysis, a large contemporary ...

Acute coronary syndrome refers to any condition that involves ... suggesting a novel immune-mediated pathway of platelet activation during a heart attack and potentially a target for therapy.

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

The acute coronary syndromes include unstable angina ... Two distinct treatment pathways exist for the treatment of unstable angina/non-STEMI: the “early invasive” strategy and the “ischemia ...

The purpose of this study is to evaluate circulating irisin as a predictor of acute coronary syndromes (ACSs) and major adverse cardiovascular events (MACE). Sub-study 1: a case–control study ...